What is the optimal initiation timing of angiotensin converting enzyme inhibitor treatment for maximum benefits in acute myocardial infarction patients?

被引：0
|
作者：
Yan Hong-bing [1 ,2 ,3 ]
Wang Shao-ping [4 ]
机构：
[1] Chinese Acad Med Sci, Coronary Heart Dis Ctr, Cardiovasc Inst, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China
[3] Peking Union Med Coll, Beijing 100037, Peoples R China
[4] Capital Med Univ, Div 28, Beijing Anzhen Hosp, Beijing 100029, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2011年 / 124卷 / 03期
关键词：
angiotensin-converting enzyme inhibitor; acute myocardial infarction; left ventricular remodeling; LEFT-VENTRICULAR DYSFUNCTION; INTRACORONARY ENALAPRILAT; THROMBOLYSIS; CAPTOPRIL; MORTALITY; FOSINOPRIL; MORBIDITY; SURVIVAL;
D O I：
10.3760/cma.j.issn.0366-6999.2011.03.026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Randomized clinical trials led to the clinical recommendation that angiotensin-converting enzyme inhibitors (ACEI) should be used as standard therapy in most patients experiencing an acute myocardial infarction (AMI). However, the optimal initiation timing of treatment, as well as the exact mechanisms, have not been completely resolved, especially with the development of reperfusion strategy after AMI. Earlier initiation of ACEI might be associated with more prompt recovery of left ventricular ejection fraction due to more rapid attenuation of negative remodeling. Chin Med J 2011;124(3):464-466
引用
收藏
页码：464 / 466
页数：3
相关论文
共 50 条
  • [21] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction
    Evans, Marie
    Carrero, Juan-Jesus
    Szummer, Karolina
    Akerblom, Axel
    Edfors, Robert
    Spaak, Jonas
    Jacobson, Stefan H.
    Andell, Pontus
    Lindhagen, Lars
    Jernberg, Tomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (14) : 1687 - 1697
  • [22] The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in elderly (≥ 65) patients with acute myocardial infarction without hypertension
    Ahn, Woo Jin
    Rha, Seung-Woon
    Choi, Byoung Geol
    Jeong, Myung Ho
    KAMIR
    NIH Investigators
    HEART AND VESSELS, 2023, 38 (07) : 898 - 908
  • [23] Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril
    Preobrazhensky, D. V.
    Sidorenko, B. A.
    Pershukov, I. V.
    Batyraliev, T. A.
    Pataraya, S. A.
    KARDIOLOGIYA, 2006, 46 (05) : 89 - 95
  • [24] Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk
    Voors, AA
    de Kam, PJ
    van den Berg, MP
    Borghi, C
    Hochman, JS
    van Veldhuisen, DJ
    van Gilst, WH
    CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (02) : 119 - 124
  • [25] Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention
    Choi, Se Yeon
    Choi, Byoung Geol
    Rha, Seung-Woon
    Byun, Jae Kyeong
    Shim, Min suk
    Li, Hu
    Mashaly, Ahmed
    Choi, Cheol Ung
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    Jeong, Myung Ho
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : 48 - 54
  • [26] Acute Administration of Angiotensin Converting Enzyme Inhibitors in Thrombolysed Myocardial Infarction Patients Is Associated with a Decreased Incidence of Heart Failure, but an Increased Re-Infarction Risk
    Adriaan A. Voors
    Pieter J. de Kam
    Maarten P. van den Berg
    Claudio Borghi
    Judith S. Hochman
    Dirk J. van Veldhuisen
    Wiek H. van Gilst
    Cardiovascular Drugs and Therapy, 2005, 19 : 119 - 124
  • [27] Beta-blockers, angiotensin-converting enzyme inhibitors, and calcium antagonists in treatment of elderly patients with acute myocardial infarction
    Aronow, WS
    CORONARY ARTERY DISEASE, 2000, 11 (04) : 331 - 338
  • [28] The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension
    Her, Ae-Young
    Choi, Byoung Geol
    Rha, Seung-Woon
    Kim, Yong Hoon
    Choi, Cheol Ung
    Jeong, Myung Ho
    PLOS ONE, 2020, 15 (11):
  • [29] Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction
    Gonzalez-Cambeiro, Maria Cristina
    Lopez-Lopez, Andrea
    Abu-Assi, Emad
    Raposeiras-Roubin, Sergio
    Pena-Gil, Carlos
    Garcia-Acuna, Jose
    Gonzalez-Juanatey, Ramon
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2016, 35 (12) : 645 - 653
  • [30] A pragmatic approach to the use of angiotensin-converting enzyme inhibitors in acute myocardial infarction
    Vantrimpont, P
    Rouleau, JL
    CANADIAN JOURNAL OF CARDIOLOGY, 1996, 12 (10) : 924 - 929
12345